[HTML][HTML] Vaccine hesitancy in migrant communities: a rapid review of latest evidence
Highlights•Clear evidence of vaccine hesitancy has been reported among migrant groups in
multiple countries.•Fear of measles vaccine harms intensified by anti-vaccination activism …
multiple countries.•Fear of measles vaccine harms intensified by anti-vaccination activism …
Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance
AB Arunachalam, P Post, D Rudin - npj Vaccines, 2021 - nature.com
The influenza vaccine field has been constantly evolving to improve the speed, scalability,
and flexibility of manufacturing, and to improve the breadth and longevity of the protective …
and flexibility of manufacturing, and to improve the breadth and longevity of the protective …
Coinfection by influenza A virus and respiratory syncytial virus produces hybrid virus particles
Interactions between respiratory viruses during infection affect transmission dynamics and
clinical outcomes. To identify and characterize virus–virus interactions at the cellular level …
clinical outcomes. To identify and characterize virus–virus interactions at the cellular level …
COVID-19 pandemic interventions reshaped the global dispersal of seasonal influenza viruses
The global dynamics of seasonal influenza viruses inform the design of surveillance,
intervention, and vaccination strategies. The COVID-19 pandemic provided a singular …
intervention, and vaccination strategies. The COVID-19 pandemic provided a singular …
[HTML][HTML] Interferon-γ promotes monocyte-mediated lung injury during influenza infection
Influenza A virus (IAV) infection triggers an exuberant host response that promotes acute
lung injury. However, the host response factors that promote the development of a …
lung injury. However, the host response factors that promote the development of a …
Safety and immunogenicity of mRNA-1010, an investigational seasonal influenza vaccine, in healthy adults: final results from a phase 1/2 randomized trial
J Ananworanich, IT Lee, D Ensz… - The Journal of …, 2024 - academic.oup.com
Background Seasonal influenza remains a global public health concern. A messenger RNA
(mRNA)–based quadrivalent seasonal influenza vaccine, mRNA-1010, was investigated in …
(mRNA)–based quadrivalent seasonal influenza vaccine, mRNA-1010, was investigated in …
Timing of seasonal influenza epidemics for 25 countries in Africa during 2010–19: a retrospective analysis
LS Igboh, K Roguski, P Marcenac… - The Lancet Global …, 2023 - thelancet.com
Background Using country-specific surveillance data to describe influenza epidemic activity
could inform decisions on the timing of influenza vaccination. We analysed surveillance data …
could inform decisions on the timing of influenza vaccination. We analysed surveillance data …
[HTML][HTML] Global and national influenza-associated hospitalisation rates: estimates for 40 countries and administrative regions
Background WHO estimates that seasonal influenza epidemics result in three to five million
cases of severe illness (hospitalisations) every year. We aimed to improve the …
cases of severe illness (hospitalisations) every year. We aimed to improve the …
Association of climatic variables with risk of transmission of influenza in Guangzhou, China, 2005–2021
R Zhang, KY Lai, W Liu, Y Liu, W Cai, C Webster… - International Journal of …, 2023 - Elsevier
Background Climatic variables constitute important extrinsic determinants of transmission
and seasonality of influenza. Yet quantitative evidence of independent associations of viral …
and seasonality of influenza. Yet quantitative evidence of independent associations of viral …
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from …
RG Bender, SB Sirota, LR Swetschinski… - The Lancet Infectious …, 2024 - thelancet.com
Summary Background Lower respiratory infections (LRIs) are a major global contributor to
morbidity and mortality. In 2020–21, non-pharmaceutical interventions associated with the …
morbidity and mortality. In 2020–21, non-pharmaceutical interventions associated with the …